| Serial Number | 98504518 |
| Word Mark | GENFAR |
| Filing Date | Wednesday, April 17, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, December 9, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | Tuesday, December 30, 2025 |
| Indication of Colors claimed | The color red is claimed as a feature of the mark. |
| Goods and Services | Business representative services in the nature of independent sales representatives, and import-export agencies, all in the fields of pharmaceutical products, pharmaceutical preparations, medicines for human and veterinary health, antibiotics, dermatological, ophthalmological, otological and homeopathic medicines, medicines for animal health and other medicines for the defense and protection of human and veterinary health |
| Goods and Services | Pharmaceutical products of chemical synthesis and biologics for human use for the prevention and treatment of acute and chronic diseases for different age groups relating to the nervous system, cardiovascular system, respiratory system, endocrine system, digestive system, genitourinary system, musculoskeletal system, sensory systems, hematopoietic system, and immune system; Pharmaceutical products in the form of prescription and non-prescription drugs, namely, pills, tablets, capsules, granulates, sachets, drops, syrups, injectables, inhalers, patches, creams, gels, suppositories, ovules, implants, and any pharmaceutical form that allows adequate administration of the drug, all for the prevention and treatment of chronic diseases for different age groups relating to the nervous system, cardiovascular system, respiratory system, endocrine system, digestive system, genitourinary system, musculoskeletal system, sensory systems, hematopoietic system, and immune system; Pharmaceutical preparations for the treatment and prevention of acute and chronic diseases of the nervous, cardiovascular, respiratory, endocrine, digestive, genitourinary, musculoskeletal, sensory, hematopoietic, and immune systems; drugs in the nature of pharmaceutical preparations for the treatment of infections caused by bacteria, viruses, fungi, parasites, and other germs; Chemical and biological preparations for medical and pharmaceutical uses for the treatment and prevention of acute and chronic diseases relating to infectious diseases, neurological diseases, psychiatric conditions, endocrinological diseases, digestive diseases, cardiovascular diseases, renal diseases, respiratory diseases, sense organ diseases, musculoskeletal diseases, and male and female reproductive organ diseases relating to contraceptives, immunological diseases, allergic conditions, inflammatory diseases, skin and adnexa dermatological diseases, oncological conditions, and hematopoietic diseases; Vaccines; Baby food; Medical plasters; Dressing materials, namely, medical dressings; Disinfectants; Vitamins; Vitamin preparations; Food supplements for medicinal purposes; Mineral food supplements for medicinal purposes; Nutritional supplements; Herbal preparations for medicinal purposes; Food supplements containing protein, carbohydrates, fat, fiber and micronutrients in the form of vitamins, mineral supplements, amino acid preparations for medicinal purposes and fatty acids for medicinal purposes |
| Translation of Words in Mark | The wording "GENFAR" has no meaning in a foreign language. |
| Description of Mark | The mark consists of the stylized word "GENFAR" in red. |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 17, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, April 17, 2024 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Genfar S.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Bogotá D.C. 111611 CO |
| Event Date | Event Description |
| Wednesday, April 17, 2024 | NEW APPLICATION ENTERED |
| Wednesday, October 2, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 30, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, October 30, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, October 30, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, October 30, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 14, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 14, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 14, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 15, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 15, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 15, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, January 28, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, January 28, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 28, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 28, 2025 | SUSPENSION LETTER WRITTEN |
| Tuesday, January 28, 2025 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, January 28, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, July 29, 2025 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, September 9, 2025 | SUSPENSION INQUIRY WRITTEN |
| Tuesday, September 9, 2025 | INQUIRY TO SUSPENSION E-MAILED |
| Tuesday, September 9, 2025 | NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED |
| Tuesday, November 25, 2025 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Tuesday, November 25, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, November 25, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, November 26, 2025 | NON-FINAL ACTION WRITTEN |
| Wednesday, November 26, 2025 | NON-FINAL ACTION E-MAILED |
| Wednesday, November 26, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, December 2, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, December 2, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, December 2, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, December 3, 2025 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, December 3, 2025 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 3, 2025 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, December 3, 2025 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, December 3, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |